Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
Public ClinicalTrials.gov record NCT06271291. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study evaluates individuals without pancreatic cancer, but who have been determined to be at higher-than-average lifetime risk of developing pancreatic cancer to help detect pancreatic cancer or other cancers at an earlier time when they might be more easily treated and cured.
Study identification
- NCT ID
- NCT06271291
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 30,000 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 12, 2024 (Actual)
- Primary completion
- Nov 1, 2029 (Estimated)
- Completion
- Nov 1, 2029 (Estimated)
- Last update posted
- Sep 21, 2026
2024 – 2029
United States locations
- U.S. sites
- 11
- U.S. states
- 11
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| HonorHealth Research Institute | Scottsdale | Arizona | 85258 | Withdrawn |
| University of California, San Francisco | San Francisco | California | 94158 | Recruiting |
| Piedmont Healthcare | Atlanta | Georgia | 30309 | Recruiting |
| OSF Saint Francis Medical Center | Peoria | Illinois | 61615 | Recruiting |
| The Johns Hopkins University School of Medicine | Baltimore | Maryland | 21231 | Recruiting |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | Recruiting |
| Mayo Clinic in Rochester | Rochester | Minnesota | 55905 | Recruiting |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198-6805 | Recruiting |
| Oregon Health & Science University | Portland | Oregon | 97201 | Recruiting |
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15232 | Recruiting |
| The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030-4009 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06271291, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 21, 2026 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06271291 live on ClinicalTrials.gov.